Prescription Drug News and Research

RSS
FDA continues review of Takeda's NDA for Alogliptin

FDA continues review of Takeda's NDA for Alogliptin

Private health plan spending growth slows in Minnesota, report finds

Private health plan spending growth slows in Minnesota, report finds

MedPAC hearing panelists call for residency programs to move away from hospital-centered care, toward treatment of chronic illnesses

MedPAC hearing panelists call for residency programs to move away from hospital-centered care, toward treatment of chronic illnesses

Average monthly premium for stand-alone Medicare prescription drug coverage will increase by 24% in 2009 to $37, according to report

Average monthly premium for stand-alone Medicare prescription drug coverage will increase by 24% in 2009 to $37, according to report

Study finds Medicare's benefits are less generous than large-employer plans

Study finds Medicare's benefits are less generous than large-employer plans

U.S. citizens cutting back on health care

U.S. citizens cutting back on health care

Medicare Part B premiums in 2009 will not increase for most beneficiaries

Medicare Part B premiums in 2009 will not increase for most beneficiaries

Utah preferred prescription drug list savings less than projected

Utah preferred prescription drug list savings less than projected

Advisers to Presidential candidates discuss positions on reimportation, generics, biotechnology medications

Advisers to Presidential candidates discuss positions on reimportation, generics, biotechnology medications

Congress approves legislation that would expand Americans with Disabilities Act

Congress approves legislation that would expand Americans with Disabilities Act

Senate hearing discusses recommendations for increased regulations on direct-to-consumer ads for medical devices

Senate hearing discusses recommendations for increased regulations on direct-to-consumer ads for medical devices

Lawmakers warn federal officials to fix problems with Medicare information phone line

Lawmakers warn federal officials to fix problems with Medicare information phone line

The Hill examines Presidential candidates' positions on prescription drug issues

The Hill examines Presidential candidates' positions on prescription drug issues

Presidential candidates discuss proposals for health care, other issues at AARP convention

Presidential candidates discuss proposals for health care, other issues at AARP convention

About 85% of insurers' marketing materials for prescription drug plans do not meet Medicare guidelines, audit finds

About 85% of insurers' marketing materials for prescription drug plans do not meet Medicare guidelines, audit finds

60% of women use herbal products during pregnancy

60% of women use herbal products during pregnancy

Survey reveals confusion of pregnant women

Survey reveals confusion of pregnant women

California health officials seek suspension of injunction against Medi-Cal reimbursement rate reduction

California health officials seek suspension of injunction against Medi-Cal reimbursement rate reduction

Democratic National Committee approves platform with health care language; Obama campaigns in Iowa

Democratic National Committee approves platform with health care language; Obama campaigns in Iowa

Lack of oversight by CMS to ensure private Medicare drug plans have anti-fraud programs in place 'risks significant use of funds,' according to GAO

Lack of oversight by CMS to ensure private Medicare drug plans have anti-fraud programs in place 'risks significant use of funds,' according to GAO

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.